Schmidt P J Investment Management Inc. Reduces Holdings in UnitedHealth Group Incorporated $UNH

Schmidt P J Investment Management Inc. reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 1.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 24,387 shares of the healthcare conglomerate’s stock after selling 436 shares during the period. UnitedHealth Group comprises approximately 2.3% of Schmidt P J Investment Management Inc.’s holdings, making the stock its 10th largest position. Schmidt P J Investment Management Inc.’s holdings in UnitedHealth Group were worth $12,772,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in UNH. Citizens National Bank Trust Department lifted its stake in UnitedHealth Group by 1.0% in the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock valued at $9,368,000 after acquiring an additional 170 shares during the last quarter. Fort Washington Investment Advisors Inc. OH lifted its stake in shares of UnitedHealth Group by 0.3% in the first quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate’s stock worth $277,641,000 after buying an additional 1,465 shares during the last quarter. Caitlin John LLC lifted its stake in shares of UnitedHealth Group by 14.8% in the first quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock worth $451,000 after buying an additional 111 shares during the last quarter. Sherbrooke Park Advisers LLC acquired a new position in UnitedHealth Group during the 4th quarter valued at $515,000. Finally, Silvercrest Asset Management Group LLC raised its stake in UnitedHealth Group by 47.8% during the 4th quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate’s stock valued at $19,625,000 after purchasing an additional 12,550 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the stock. Truist Financial upped their target price on shares of UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a report on Tuesday. Deutsche Bank Aktiengesellschaft lowered their target price on shares of UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating on the stock in a report on Wednesday, May 14th. Raymond James Financial lowered shares of UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a report on Wednesday, May 14th. TD Cowen lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price objective on the stock. in a report on Monday, May 19th. Finally, Robert W. Baird reissued an “underperform” rating and set a $198.00 price objective (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Sixteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $355.77.

UnitedHealth Group Stock Up 8.8%

UNH opened at $348.59 on Wednesday. The company has a market capitalization of $315.71 billion, a P/E ratio of 15.10, a P/E/G ratio of 2.09 and a beta of 0.45. The stock has a fifty day moving average of $289.41 and a 200-day moving average of $371.39. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same period in the previous year, the firm posted $6.80 EPS. The firm’s revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be given a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.